- Published at
- by investing.com
mixed
mixed
Earnings call: Altimmune reports progress in pemvidutide trials By Investing.com
Earnings call: Altimmune reports progress in pemvidutide trials
News for PharmAthene, Inc (PIP)
- Published at
- by etfdailynews.com
positivepositiveRecent Research Analysts’ Ratings Changes for Altimmune (ALT)
Read Recent Research Analysts’ Ratings Changes for Altimmune (ALT) at ETF Daily News- Published at
- by etfdailynews.com
positivepositiveAltimmune (NASDAQ:ALT) Upgraded at Zacks Investment Research
Read Altimmune (NASDAQ:ALT) Upgraded at Zacks Investment Research at ETF Daily News- Published at
- by etfdailynews.com
mixedmixedInvestment Analysts’ Updated EPS Estimates for May 20th (ABG, ACER, ADTH, AIRG, ALSMY, ALT, AMNB, AMPS, APELY, APEMY)
Read Investment Analysts’ Updated EPS Estimates for May 20th (ABG, ACER, ADTH, AIRG, ALSMY, ALT, AMNB, AMPS, APELY, APEMY) at ETF Daily News- Published at
- by etfdailynews.com
positivepositiveAltimmune (NASDAQ:ALT) Lowered to “Hold” at Zacks Investment Research
Altimmune (NASDAQ:ALT) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Wednesday, Zacks.com reports. According to Zacks, “Altimmune, Inc. is a clinical-stage immunotherapeutics company. It focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment of disease. […]- Published at
- by etfdailynews.com
positivepositiveAltimmune (NASDAQ:ALT) Upgraded by Zacks Investment Research to Buy
Altimmune (NASDAQ:ALT) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Wednesday, Zacks.com reports. The brokerage currently has a $8.25 price objective on the stock. Zacks Investment Research‘s target price would suggest a potential upside of 18.53% from the stock’s current price. According to Zacks, […]- Published at
- by investopedia.com
mixedmixedHow Legally Binding Is a Letter of Intent?
Find out when a letter of intent (LOI) is binding and non-binding. Understand the role of drafting language, and when an LOI is treated like a contract.